Neurotensin regulates DARPP-32 Thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors

Journal of Neurochemistry

Volumn 81, Issue 2, 2002, Pages 325-334

  Matsuyama, Seiichiro ^a   Higashi, Hideho ^a   Maeda, Hisao ^a   Greengard, Paul ^b   Nishi, Akinori ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

DARPP 32; Dopamine; Glutamate; Neostriatum; Neurotensin; Phosphorylation

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; COBALT; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; LEVOCABASTINE; NEUROTENSIN; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; IMMUNOBLOTTING; KNOCKOUT MOUSE; MALE; MOUSE; NEOSTRIATUM; NERVE CELL; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

ANIMALS; COBALT; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMINE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONS; NEUROTENSIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PIPERIDINES; PYRAZOLES; QUINOLINES; RECEPTORS, DOPAMINE D1; RECEPTORS, NEUROTENSIN; SIGNAL TRANSDUCTION; TETRODOTOXIN;

ANIMALIA;

EID: 0036316686     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00822.x     Document Type: Article

References (64)

1. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain
2. 3H] levocabastine
3. Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: A detailed cellular co-expression study
4. Control of GluR1 AMPA receptor fimction function by cAMP-dependent protein kinase
5. Neurotensin effect on dopamine release and calcium transport in rat striatum: Interactions with diphenylalkylamine calcium antagonists
6. 3H]SR 48692, in the guinea pig brain
7. Nonpeptide antagonists of neuropeptide receptors: Tools for research and therapy
8. Cellular distribution of neurotensin receptors in rat brain: Immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor
9. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami
10. Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach
11. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain
12. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat
13. Excitatory amino acids in synaptic excitation of rat striatal neurons in vitro
14. 1-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-D-aspartate receptors
15. Involvement of glutamate receptors in the striatal enkephalin-induced dopamine release
16. Identification of the receptor subtype involved in the analgesic effect of neurotensin
17. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat
18. The DARPP-32 knockout mouse
19. DARPP-32, regulator of the efficacy of dopaminergic neurotransmission
20. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensindopamine receptor interactions in the neostriatum
21. The neostriatal mosaic: Multiple levels of compartmental organization
22. Presynaptic effect of 1-glutamic acid on the release of dopamine in rat striatal slices
23. Ultrastructural immunocytochemical localization of the N-methyl-D-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens
24. Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocampal neurons
25. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
26. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor
27. Biochemical and pharmacological activities of SR142948A, a new potent neurotensin receptor antagonist
28. Activation of NMDA receptors induced dephosphorylation of DARPP-32 in rat striatal slices
29. Somatostatin potently stimulates in vivo striatal dopamine and gamma-aminobutyric acid release by a glutamate-dependent action
30. 3H]dopamine release evoked by KCl versus electrical depolarization
31. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein: Regional, tissue, and phylogenetic distribution
32. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1
33. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat
34. Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression
35. The neurobiology of neurotensin: Focus on neurotensin-dopamine interactions
36. Does neurotensin mediate the effects of antipsychotic drugs?
37. Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways
38. Neurotensin: Perchance an endogenous neuroleptic?
39. Bidirectional regulation of DARPP-32 phosphorylation by dopamine
40. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons
41. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: Distinct roles of calcineurin and protein phosphatase-2A
42. The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: An in vivo microdialysis study
43. Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: Involvement of both NMDA and AMPA/kainate subtypes
44. Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices
45. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization
46. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain
47. 3H]dopamine from rat striatal slices
48. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
49. Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain
50. 3H]neurotensin binding site in rat brain
51. Different subcellular localization of neurotensin-receptor and neurotensin-acceptor sites in the rat brain dopaminergic system
52. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: Regulation by factors other than dopamine
53. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo
54. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: An immunohistochemical study in the cat
55. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocullulose sheets: Procedure and some applications
56. Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: Evidence for the involvement of multiple receptors
57. Neurotensin: Peptide for the next millennium
58. Neurotensin receptors: Binding properties, transduction pathways, and structure
59. Neurotensin and neurotensin receptors
60. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis
61. Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens
62. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular disrtribution in rat brain
63. Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases
64. Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin